Literature DB >> 1685489

Beta-adrenoceptor distribution in murine lymphoid cell lines.

G A Cremaschi1, P Fisher, F Boege.   

Abstract

beta-Adrenergic receptors (R) on several tumor lymphoid cell lines were characterized both directly by beta radioligand binding of 125iodo-cyanopindolol (125I-CYP) to intact cells and membranes, and functionally by assessing hormone-dependent changes in cyclic 3',5' adenosine monophosphate (cAMP) levels on intact cells and measuring adenylate cyclase (a.c.) activity on membranes. Only two lymphoid cell types, BW 5147 (a T cell derived lymphoma cell line) and TIB 221 (a B cell derived line) displayed significant amounts of beta-adrenergic R by 125I-CYP specific binding. Despite this, no stimulation of the a.c. activity was found in the presence of beta-adrenergic agonists in these cells in comparison with native lymphocytes or cells of the well-known S49 cell line used as a positive control. beta-Adrenoceptor specific uncoupling was confirmed by aluminum tetrafluoride (AlFl4) direct activation of the a.c. system in the beta R-bearing cell membranes and by an increase in cAMP production induced by PGE1, another hormone that activates the a.c. Structural characterization of beta-adrenoceptors by photoaffinity-labeling demonstrates that uncoupling was not due to a structural alteration of the beta-adrenergic R expressed in these lymphoma cell lines, as these R gave similar results as native or S49 cells. It can be concluded that functional beta-adrenoceptors are absent in these lymphoma cells. The possible implication of alternative transmission pathways and original neuroendocrine control in tumor lymphoid cells is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1685489     DOI: 10.1016/0162-3109(91)90044-y

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  7 in total

Review 1.  Sympathetic modulation of immunity: relevance to disease.

Authors:  Denise L Bellinger; Brooke A Millar; Sam Perez; Jeff Carter; Carlo Wood; Srinivasan ThyagaRajan; Christine Molinaro; Cheri Lubahn; Dianne Lorton
Journal:  Cell Immunol       Date:  2008-03-04       Impact factor: 4.868

2.  Dissecting the role of cell signaling versus CD8+ T cell modulation in propranolol antitumor activity.

Authors:  Wei Li; Jielin Wan; Cuiyu Chen; Chengfang Zhou; Ping Liao; Qian Hu; Jiali Hu; Yang Wang; Yu Zhang; Cong Peng; Yuanfei Huang; Weihua Huang; Wei Zhang; Howard L Mcleod; Yijing He
Journal:  J Mol Med (Berl)       Date:  2022-07-27       Impact factor: 5.606

Review 3.  Autonomic nervous system and immune system interactions.

Authors:  M J Kenney; C K Ganta
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

Review 4.  β-Adrenergic Signaling in Lung Cancer: A Potential Role for Beta-Blockers.

Authors:  Monique B Nilsson; Xiuning Le; John V Heymach
Journal:  J Neuroimmune Pharmacol       Date:  2019-12-11       Impact factor: 4.147

Review 5.  Stress reduction strategies in breast cancer: review of pharmacologic and non-pharmacologic based strategies.

Authors:  Rohit Gosain; Elizabeth Gage-Bouchard; Christine Ambrosone; Elizabeth Repasky; Shipra Gandhi
Journal:  Semin Immunopathol       Date:  2020-09-18       Impact factor: 9.623

Review 6.  Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response.

Authors:  Guanxi Qiao; Minhui Chen; Mark J Bucsek; Elizabeth A Repasky; Bonnie L Hylander
Journal:  Front Immunol       Date:  2018-02-06       Impact factor: 7.561

7.  β-Adrenergic signaling blocks murine CD8+ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress.

Authors:  Guanxi Qiao; Mark J Bucsek; Nicolette M Winder; Minhui Chen; Thejaswini Giridharan; Scott H Olejniczak; Bonnie L Hylander; Elizabeth A Repasky
Journal:  Cancer Immunol Immunother       Date:  2018-09-18       Impact factor: 6.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.